Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
August 14, 2009
IN THIS ISSUE
FDA six-step plan
Clinical trial corruption
Green manufacturing
FDA guidance issued
More...

Six-step plan for improved FDA enforcement
FDA Commissioner Margaret Hamburg has outlined six initial steps designed to improve the effectiveness and timeliness of FDA’s regulatory and enforcement system. More...

Corruption in clinical trials
Jim Miller explains why corruption is a more important issue as the pharmaceutical industry looks to emerging markets. More...

Green manufacturing with marine microbes
Manufacturing methods for new drugs could be made greener and more efficient with the help of marine microbes. More...

FDA guidance on monitoring at-risk melamine contamination
The FDA has released its Guidance for Industry titled Pharmaceutical Components at Risk for Melamine Contamination. More...

Antipsychotic drugs dominate
There is a considerable commercial opportunity for developers of antipsychotic drugs, according to market analysts Datamonitor, who claim that this class of drugs dominates the US market and boasted a global value of approximately $22 billion in 2008. More...

GSK buys rights to staph infection vaccine
GlaxoSmithKline (GSK) has signed an agreement to acquire US-based Nabi Biopharmaceuticals' PentaStaph programme, which will provide the company with a five component vaccine candidate for Pentavalent S. aureus. More...

BIO asks Supreme Court to overturn Bilski
The Biotechnology Industry Organization (BIO) has filed an amicus brief asking the US Supreme Court to overturn Bilski versus Doll, a decision of the US Court of Appeals for the Federal Circuit. The case involves Bernard L. Bilski's method for hedging risks in commodities trading. More...

Are you LinkedIn?
So are we. Why not join our group of industry experts? More...

Profile

Property Measurement and Testing of Powders for Pharmaceutical / Neutraceutical Production

A one-day seminar hosted by the University of Greenwich focusing on the practicalities of achieving and maintaining production of high quality products whilst minimising the generation of out-of specification materials. The day represents an opportunity to familiarise with some of the latest scientific techniques for improving formulation and processing performance.

Read more…

Key Topic Updates
September events
PharmaManufacturersArena.com (UK)
Biological Production 2009 (UK)
Adverse Drug Events — Reporting & Regulatory Requirements (Ireland)
Submit your event
 
Analyical
Dynamic avalanching accurately assesses flowability and quality
Characterizing amorphous materials with gravimetric vapour sorption techniques
Particle size analysis
More analytical articles
 
Formulation
Improving liposome integrity and easing bottlenecks to production
Formulation effects on the thermomechanical properties and permeability of free films and coating films
Narrowing the gap between clinical capsule formulations and commercial film-coated tablets
More formulation articles

Key Topic Updates

Survey
When do you read Pharmaceutical Technology Europe?
  At Home 8%
  Commuting/travelling 12%
  At work, but in own time 16%
  At work in work time 60%
  Other 4%

This week we would like to know...

Do you believe that most pharmaceutical manufacturers will eventually adopt microreactor technology for continuous, large-scale processing?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.


You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.comor by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.